Skip to main content

Table 2 Oral glucose tolerance test serum glucose levels at baseline and after the 6-week intervention

From: Antihyperglycemic effect of short-term arginyl-fructose supplementation in subjects with prediabetes and newly diagnosed type 2 diabetes: randomized, double-blinded, placebo-controlled trial

 

Placebo (n = 24)

Test (n = 25)

Glucose (mg/dL)a

  

 0 minutes

  

  0 week

114.0 ± 2.50

114.6 ± 2.19

  6 week

120.4 ± 3.54

114.4 ± 4.35

 30 minutes

  

  0 week

212.6 ± 7.78

197.9 ± 8.11

  6 week

198.3 ± 6.42*

178.6 ± 7.36**

 60 minutes

  

  0 week

235.4 ± 10.61

209.3 ± 11.70

  6 week

233.6 ± 6.79

194.0 ± 11.59*

 120 minutes

  

  0 week

196.6 ± 12.01

183.1 ± 13.19

  6 week

187.5 ± 8.68

170.9 ± 13.39

Glucose AUC (mg/dL per hour)a

  

 0 week

409.7 ± 15.61

376.2 ± 17.38

 6 week

398.2 ± 11.14

348.8 ± 16.55**

  1. Data are shown as mean ± SEM
  2. †p < 0.1, *p < 0.05, **p < 0.01, compared to 0 week, tested by paired t-test
  3. aAnalyzed after log transformation
  4. AUC Area under the curve
Back to article page

Trials

ISSN: 1745-6215